Cargando…
Clostridium difficile infection: a review of current and emerging therapies
Clostridium difficile (C. difficile) infection (CDI) is the most common cause of healthcare-associated infections in US hospitals. The epidemic strain NAP1/BI/ribotype 027 accounts for outbreaks worldwide, with increasing mortality and severity. CDI is acquired from an endogenous source or from spo...
Autor principal: | Ofosu, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805733/ https://www.ncbi.nlm.nih.gov/pubmed/27065726 http://dx.doi.org/10.20524/aog.2016.0006 |
Ejemplares similares
-
Emerging therapies for Clostridium difficile infection – focus on fidaxomicin
por: Chaparro-Rojas, Fredy, et al.
Publicado: (2013) -
Clostridium difficile infection: review
por: Czepiel, Jacek, et al.
Publicado: (2019) -
Current advances related to Clostridium difficile infection
por: Kim, Yong Gil, et al.
Publicado: (2015) -
Current knowledge on the laboratory diagnosis of Clostridium difficile infection
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2017) -
Rational Therapy of Clostridium difficile Infections
por: Keller, Peter M., et al.
Publicado: (2014)